Junpei Sanada

611 total citations
64 papers, 386 citations indexed

About

Junpei Sanada is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Junpei Sanada has authored 64 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Endocrinology, Diabetes and Metabolism, 24 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Junpei Sanada's work include Diabetes Treatment and Management (21 papers), Diabetes Management and Research (18 papers) and Pancreatic function and diabetes (17 papers). Junpei Sanada is often cited by papers focused on Diabetes Treatment and Management (21 papers), Diabetes Management and Research (18 papers) and Pancreatic function and diabetes (17 papers). Junpei Sanada collaborates with scholars based in Japan, Spain and United States. Junpei Sanada's co-authors include Yoshiro Fushimi, Masashi Shimoda, Kohei Kaku, Hideaki Kaneto, Shuhei Nakanishi, Tomoatsu Mune, Atsushi Obata, Tomohiko Kimura, Kenji Kohara and Fuminori Tatsumi and has published in prestigious journals such as Diabetes, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Junpei Sanada

52 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junpei Sanada Japan 10 257 144 101 93 70 64 386
Yoshiro Fushimi Japan 11 271 1.1× 148 1.0× 105 1.0× 99 1.1× 78 1.1× 67 405
Fuminori Tatsumi Japan 10 272 1.1× 151 1.0× 97 1.0× 105 1.1× 73 1.0× 65 423
Noboru Kurinami Japan 11 293 1.1× 124 0.9× 99 1.0× 136 1.5× 120 1.7× 24 440
Kazuhiko Matsuzawa Japan 12 182 0.7× 96 0.7× 72 0.7× 158 1.7× 63 0.9× 30 452
Guoyu Tong China 9 231 0.9× 93 0.6× 120 1.2× 117 1.3× 39 0.6× 10 336
Keizo Kajiwara Japan 11 270 1.1× 115 0.8× 98 1.0× 136 1.5× 119 1.7× 30 432
Fumio Miyamoto Japan 11 265 1.0× 104 0.7× 98 1.0× 132 1.4× 114 1.6× 18 404
Hannes Manell Sweden 10 222 0.9× 177 1.2× 115 1.1× 76 0.8× 112 1.6× 21 433
Magnus F.G. Grøndahl Denmark 7 352 1.4× 207 1.4× 45 0.4× 169 1.8× 52 0.7× 13 419
Emir Muzurović Montenegro 12 270 1.1× 131 0.9× 232 2.3× 126 1.4× 106 1.5× 29 540

Countries citing papers authored by Junpei Sanada

Since Specialization
Citations

This map shows the geographic impact of Junpei Sanada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junpei Sanada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junpei Sanada more than expected).

Fields of papers citing papers by Junpei Sanada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junpei Sanada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junpei Sanada. The network helps show where Junpei Sanada may publish in the future.

Co-authorship network of co-authors of Junpei Sanada

This figure shows the co-authorship network connecting the top 25 collaborators of Junpei Sanada. A scholar is included among the top collaborators of Junpei Sanada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junpei Sanada. Junpei Sanada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Iwamoto, Yuichiro, Tomohiko Kimura, Junpei Sanada, et al.. (2025). Development of a prediction model by combining tumor diameter and clinical parameters of adrenal incidentaloma. Endocrine Journal. 72(10). 1115–1125.
3.
4.
Fushimi, Yoshiro, Tomohiko Kimura, Junpei Sanada, et al.. (2025). Rhabdomyolysis triggered by initiation of tirzepatide. Diabetology International. 16(3). 591–594. 1 indexed citations
5.
Kimura, Tomohiko, Yuichiro Iwamoto, Junpei Sanada, et al.. (2024). Usefulness of Once‐Weekly GLP‐1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study. Journal of Diabetes Research. 2024(1). 5880589–5880589. 2 indexed citations
6.
Nakanishi, Shuhei, Masashi Shimoda, Tomohiko Kimura, et al.. (2024). The Impact of Hand Strength on HbA1c, Body Mass Index and Body Composition by Group According to Sedentary Behaviour: Cross-Sectional Study in Japanese Patients with Type 2 Diabetes Mellitus. Malaysian Journal of Medical Sciences. 31(3). 185–193.
7.
Iwamoto, Yuichiro, Tomohiko Kimura, Masashi Shimoda, et al.. (2024). C‐peptide index at 2 h post‐meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes. Diabetes Obesity and Metabolism. 26(7). 2761–2773.
8.
Iwamoto, Yuichiro, Tomohiko Kimura, Junpei Sanada, et al.. (2024). Dipeptidyl peptidase‐4 inhibitor and sodium‐glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high‐fat diet‐fed mice. Diabetes Obesity and Metabolism. 26(6). 2339–2348. 5 indexed citations
9.
10.
11.
Nakanishi, Shuhei, Masashi Shimoda, Tomohiko Kimura, et al.. (2024). The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus. Journal of Diabetes Investigation. 15(7). 892–898. 2 indexed citations
12.
Iwamoto, Yuichiro, Tomohiko Kimura, Takashi Itoh, et al.. (2024). Clinical findings of acute necrotizing esophagitis complicated by diabetic ketoacidosis. Endocrine Journal. 71(5). 481–488. 1 indexed citations
13.
Kimura, Tomohiko, Junpei Sanada, Yoshiro Fushimi, et al.. (2024). Nilotinib-induced Diabetes in Japanese Patients with Chronic Myeloid Leukemia. Internal Medicine. 64(6). 817–823. 1 indexed citations
14.
Sanada, Junpei, Tomohiko Kimura, Masashi Shimoda, et al.. (2024). Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ. Cardiovascular Diabetology. 23(1). 105–105. 5 indexed citations
15.
Iwamoto, Yuichiro, Tomohiko Kimura, Fuminori Tatsumi, et al.. (2022). Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus. Frontiers in Endocrinology. 13. 871660–871660. 3 indexed citations
16.
Fushimi, Yoshiro, Shinji Kamei, Fuminori Tatsumi, et al.. (2021). Multiple endocrine neoplasia type 1 with a frameshift mutation in its gene accompanied by a giant cervical lipoma and multiple fatty deposits in the pancreas: case report. BMC Endocrine Disorders. 21(1). 164–164. 3 indexed citations
17.
Nakanishi, Shuhei, Masashi Shimoda, Fuminori Tatsumi, et al.. (2021). Clinical Characteristics of Withdrawal of Basal Insulin Therapy Among Japanese Patients with Type 2 Diabetes: A Multicenter Retrospective Observational Study. Diabetes Therapy. 12(7). 1849–1860.
18.
Nakanishi, Shuhei, Hidenori Hirukawa, Masashi Shimoda, et al.. (2019). Eicosapentaenoic acid/arachidonic acid ratio and weight loss during hospitalization for glycemic control among overweight Japanese patients with type 2 diabetes: a retrospective observational study. Lipids in Health and Disease. 18(1). 36–36. 8 indexed citations
19.
20.
Kinoshita, Tomoe, Masashi Shimoda, Junpei Sanada, et al.. (2016). Association of GA/HbA1c ratio and cognitive impairment in subjects with type 2 diabetes mellitus. Journal of Diabetes and its Complications. 30(8). 1452–1455. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiro Fushimi Breakdown of academic impact, for papers by Fuminori Tatsumi Breakdown of academic impact, for papers by Noboru Kurinami Breakdown of academic impact, for papers by Kazuhiko Matsuzawa Breakdown of academic impact, for papers by Guoyu Tong Breakdown of academic impact, for papers by Keizo Kajiwara Breakdown of academic impact, for papers by Fumio Miyamoto Breakdown of academic impact, for papers by Hannes Manell Breakdown of academic impact, for papers by Magnus F.G. Grøndahl Breakdown of academic impact, for papers by Emir Muzurović
Rankless by CCL
2026